The effect of switching from oral low-dose aripiprazole to aripiprazole once-monthly 300 mg on the quality of life in three patients with schizophrenia

BACKGROUND: Schizophrenia is a chronic disease that requires long-term management with antipsychotics; however, an important barrier to the success of long-term treatment is drug noncompliance, which increases the risk of recurrence and hospitalization. Second-generation long-acting injectable antip...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Hidenobu, Hibino, Hiroyuki, Inoue, Yuichi, Matsumoto, Hideo, Mikami, Katsunaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448866/
https://www.ncbi.nlm.nih.gov/pubmed/28596830
http://dx.doi.org/10.1177/2050313X17710594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448866/
https://www.ncbi.nlm.nih.gov/pubmed/28596830
http://dx.doi.org/10.1177/2050313X17710594

Ejemplares similares